Pay in 4 interest-free payments of $6.13 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
This launch is an important step in our ambition to expand access to innovative obesity care and broaden treatment options for people living with obesity in the UAE," said Venkat Kalyan, general manager, Novo Nordisk Gulf
The role of glutamate homeostasis in the pathophysiology of SUD and its implications for pharmacotherapy
It's comprehensive
Allogenic bone marrow-derived mesenchymal stromal cell-based therapy for patients with chronic low back pain: a prospective, multicentre, randomised placebo controlled trial (RESPINE study)
US$ 26.60
US$ 20.15
US$ 28.77
